Home/Filings/4/0001437749-25-002628
4//SEC Filing

Thompson Rahsaan 4

Accession 0001437749-25-002628

CIK 0001434647other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 5:23 PM ET

Size

8.3 KB

Accession

0001437749-25-002628

Insider Transaction Report

Form 4
Period: 2025-01-30
Thompson Rahsaan
Chief Legal & ComplianceOther
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-30+68,00068,000 total
    Exercise: $8.02Exp: 2035-01-29Common Stock (68,000 underlying)
  • Award

    Restricted Stock Unit

    2025-01-30+34,00034,000 total
    Common Stock (34,000 underlying)
Footnotes (3)
  • [F1]Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F3]The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date.

Issuer

ZEVRA THERAPEUTICS, INC.

CIK 0001434647

Entity typeother

Related Parties

1
  • filerCIK 0001788524

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:23 PM ET
Size
8.3 KB